Literature DB >> 22684479

The intermediate filament protein, vimentin, is a regulator of NOD2 activity.

Craig Stevens1, Paul Henderson, Elaine R Nimmo, Dinesh C Soares, Belgin Dogan, Kenneth W Simpson, Jeffrey C Barrett, David C Wilson, Jack Satsangi.   

Abstract

OBJECTIVE: Mutations in the nucleotide-binding oligomerisation domain-containing protein 2 (NOD2) gene remain the strongest genetic determinants for Crohn's disease (CD). Having previously identified vimentin as a novel NOD2-interacting protein, the authors aimed to investigate the regulatory effects of vimentin on NOD2 function and the association of variants in Vim with CD susceptibility.
DESIGN: Coimmunoprecipitation, fluorescent microscopy and fractionation were used to confirm the interaction between NOD2 and vimentin. HEK293 cells stably expressing wild-type NOD2 or a NOD2 frameshift variant (L1007fs) and SW480 colonic epithelial cells were used alongside the vimentin inhibitor, withaferin A (WFA), to assess effects on NOD2 function using the nuclear factor-kappaB (NF-κB) reporter gene, green fluorescent protein-LC3-based autophagy, and bacterial gentamicin protection assays. International genome-wide association meta-analysis data were used to test for associations of single-nucleotide polymorphisms in Vim with CD susceptibility.
RESULTS: The leucine-rich repeat domain of NOD2 contained the elements required for vimentin binding; CD-associated polymorphisms disrupted this interaction. NOD2 and vimentin colocalised at the cell plasma membrane, and cytosolic mislocalisation of the L1007fs and R702W variants correlated with an inability to interact with vimentin. Use of WFA demonstrated that vimentin was required for NOD2-dependent NF-κB activation and muramyl dipeptide-induced autophagy induction, and that NOD2 and vimentin regulated the invasion and survival properties of a CD-associated adherent-invasive Escherichia coli strain. Genetic analysis revealed an association signal across the haplotype block containing Vim.
CONCLUSION: Vimentin is an important regulator of NOD2 function and a potential novel therapeutic target in the treatment of CD. In addition, Vim is a candidate susceptibility gene for CD, supporting the functional data.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22684479      PMCID: PMC4225453          DOI: 10.1136/gutjnl-2011-301775

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  38 in total

1.  Modulation of Nod2-dependent NF-kappaB signaling by the actin cytoskeleton.

Authors:  Sylvie Legrand-Poels; Gaelle Kustermans; Françoise Bex; Elisabeth Kremmer; Thomas A Kufer; Jacques Piette
Journal:  J Cell Sci       Date:  2007-03-13       Impact factor: 5.285

Review 2.  Manipulation of host-cell pathways by bacterial pathogens.

Authors:  Amit P Bhavsar; Julian A Guttman; B Brett Finlay
Journal:  Nature       Date:  2007-10-18       Impact factor: 49.962

3.  The NOD2-RICK complex signals from the plasma membrane.

Authors:  Patrick Lécine; Sophie Esmiol; Jean-Yves Métais; Cendrine Nicoletti; Claire Nourry; Christine McDonald; Gabriel Nunez; Jean-Pierre Hugot; Jean-Paul Borg; Vincent Ollendorff
Journal:  J Biol Chem       Date:  2007-03-13       Impact factor: 5.157

4.  Withaferin A inhibits tumor necrosis factor-alpha-induced expression of cell adhesion molecules by inactivation of Akt and NF-kappaB in human pulmonary epithelial cells.

Authors:  Jung Hwa Oh; Taeg Kyu Kwon
Journal:  Int Immunopharmacol       Date:  2009-02-21       Impact factor: 4.932

Review 5.  Multiple roles of the cytoskeleton in autophagy.

Authors:  Iryna Monastyrska; Ester Rieter; Daniel J Klionsky; Fulvio Reggiori
Journal:  Biol Rev Camb Philos Soc       Date:  2009-08

6.  The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin.

Authors:  Paola Bargagna-Mohan; Adel Hamza; Yang-eon Kim; Yik Khuan Abby Ho; Nirit Mor-Vaknin; Nicole Wendschlag; Junjun Liu; Robert M Evans; David M Markovitz; Chang-Guo Zhan; Kyung Bo Kim; Royce Mohan
Journal:  Chem Biol       Date:  2007-06

7.  Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum.

Authors:  Martin Baumgart; Belgin Dogan; Mark Rishniw; Gil Weitzman; Brian Bosworth; Rhonda Yantiss; Renato H Orsi; Martin Wiedmann; Patrick McDonough; Sung Guk Kim; Douglas Berg; Ynte Schukken; Ellen Scherl; Kenneth W Simpson
Journal:  ISME J       Date:  2007-07-12       Impact factor: 10.302

8.  Nod2 is required for the regulation of commensal microbiota in the intestine.

Authors:  Tanja Petnicki-Ocwieja; Tomas Hrncir; Yuen-Joyce Liu; Amlan Biswas; Tomas Hudcovic; Helena Tlaskalova-Hogenova; Koichi S Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-01       Impact factor: 11.205

Review 9.  Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes.

Authors:  Daniel J Klionsky; Hagai Abeliovich; Patrizia Agostinis; Devendra K Agrawal; Gjumrakch Aliev; David S Askew; Misuzu Baba; Eric H Baehrecke; Ben A Bahr; Andrea Ballabio; Bruce A Bamber; Diane C Bassham; Ettore Bergamini; Xiaoning Bi; Martine Biard-Piechaczyk; Janice S Blum; Dale E Bredesen; Jeffrey L Brodsky; John H Brumell; Ulf T Brunk; Wilfried Bursch; Nadine Camougrand; Eduardo Cebollero; Francesco Cecconi; Yingyu Chen; Lih-Shen Chin; Augustine Choi; Charleen T Chu; Jongkyeong Chung; Peter G H Clarke; Robert S B Clark; Steven G Clarke; Corinne Clavé; John L Cleveland; Patrice Codogno; María I Colombo; Ana Coto-Montes; James M Cregg; Ana Maria Cuervo; Jayanta Debnath; Francesca Demarchi; Patrick B Dennis; Phillip A Dennis; Vojo Deretic; Rodney J Devenish; Federica Di Sano; J Fred Dice; Marian Difiglia; Savithramma Dinesh-Kumar; Clark W Distelhorst; Mojgan Djavaheri-Mergny; Frank C Dorsey; Wulf Dröge; Michel Dron; William A Dunn; Michael Duszenko; N Tony Eissa; Zvulun Elazar; Audrey Esclatine; Eeva-Liisa Eskelinen; László Fésüs; Kim D Finley; José M Fuentes; Juan Fueyo; Kozo Fujisaki; Brigitte Galliot; Fen-Biao Gao; David A Gewirtz; Spencer B Gibson; Antje Gohla; Alfred L Goldberg; Ramon Gonzalez; Cristina González-Estévez; Sharon Gorski; Roberta A Gottlieb; Dieter Häussinger; You-Wen He; Kim Heidenreich; Joseph A Hill; Maria Høyer-Hansen; Xun Hu; Wei-Pang Huang; Akiko Iwasaki; Marja Jäättelä; William T Jackson; Xuejun Jiang; Shengkan Jin; Terje Johansen; Jae U Jung; Motoni Kadowaki; Chanhee Kang; Ameeta Kelekar; David H Kessel; Jan A K W Kiel; Hong Pyo Kim; Adi Kimchi; Timothy J Kinsella; Kirill Kiselyov; Katsuhiko Kitamoto; Erwin Knecht; Masaaki Komatsu; Eiki Kominami; Seiji Kondo; Attila L Kovács; Guido Kroemer; Chia-Yi Kuan; Rakesh Kumar; Mondira Kundu; Jacques Landry; Marianne Laporte; Weidong Le; Huan-Yao Lei; Michael J Lenardo; Beth Levine; Andrew Lieberman; Kah-Leong Lim; Fu-Cheng Lin; Willisa Liou; Leroy F Liu; Gabriel Lopez-Berestein; Carlos López-Otín; Bo Lu; Kay F Macleod; Walter Malorni; Wim Martinet; Ken Matsuoka; Josef Mautner; Alfred J Meijer; Alicia Meléndez; Paul Michels; Giovanni Miotto; Wilhelm P Mistiaen; Noboru Mizushima; Baharia Mograbi; Iryna Monastyrska; Michael N Moore; Paula I Moreira; Yuji Moriyasu; Tomasz Motyl; Christian Münz; Leon O Murphy; Naweed I Naqvi; Thomas P Neufeld; Ichizo Nishino; Ralph A Nixon; Takeshi Noda; Bernd Nürnberg; Michinaga Ogawa; Nancy L Oleinick; Laura J Olsen; Bulent Ozpolat; Shoshana Paglin; Glen E Palmer; Issidora Papassideri; Miles Parkes; David H Perlmutter; George Perry; Mauro Piacentini; Ronit Pinkas-Kramarski; Mark Prescott; Tassula Proikas-Cezanne; Nina Raben; Abdelhaq Rami; Fulvio Reggiori; Bärbel Rohrer; David C Rubinsztein; Kevin M Ryan; Junichi Sadoshima; Hiroshi Sakagami; Yasuyoshi Sakai; Marco Sandri; Chihiro Sasakawa; Miklós Sass; Claudio Schneider; Per O Seglen; Oleksandr Seleverstov; Jeffrey Settleman; John J Shacka; Irving M Shapiro; Andrei Sibirny; Elaine C M Silva-Zacarin; Hans-Uwe Simon; Cristiano Simone; Anne Simonsen; Mark A Smith; Katharina Spanel-Borowski; Vickram Srinivas; Meredith Steeves; Harald Stenmark; Per E Stromhaug; Carlos S Subauste; Seiichiro Sugimoto; David Sulzer; Toshihiko Suzuki; Michele S Swanson; Ira Tabas; Fumihiko Takeshita; Nicholas J Talbot; Zsolt Tallóczy; Keiji Tanaka; Kozo Tanaka; Isei Tanida; Graham S Taylor; J Paul Taylor; Alexei Terman; Gianluca Tettamanti; Craig B Thompson; Michael Thumm; Aviva M Tolkovsky; Sharon A Tooze; Ray Truant; Lesya V Tumanovska; Yasuo Uchiyama; Takashi Ueno; Néstor L Uzcátegui; Ida van der Klei; Eva C Vaquero; Tibor Vellai; Michael W Vogel; Hong-Gang Wang; Paul Webster; John W Wiley; Zhijun Xi; Gutian Xiao; Joachim Yahalom; Jin-Ming Yang; George Yap; Xiao-Ming Yin; Tamotsu Yoshimori; Li Yu; Zhenyu Yue; Michisuke Yuzaki; Olga Zabirnyk; Xiaoxiang Zheng; Xiongwei Zhu; Russell L Deter
Journal:  Autophagy       Date:  2007-11-21       Impact factor: 16.016

10.  Activation of innate immune antiviral responses by Nod2.

Authors:  Ahmed Sabbah; Te Hung Chang; Rosalinda Harnack; Victoria Frohlich; Kaoru Tominaga; Peter H Dube; Yan Xiang; Santanu Bose
Journal:  Nat Immunol       Date:  2009-08-23       Impact factor: 25.606

View more
  35 in total

Review 1.  NOD proteins: regulators of inflammation in health and disease.

Authors:  Dana J Philpott; Matthew T Sorbara; Susan J Robertson; Kenneth Croitoru; Stephen E Girardin
Journal:  Nat Rev Immunol       Date:  2013-12-13       Impact factor: 53.106

Review 2.  Intermediate Filaments and the Plasma Membrane.

Authors:  Jonathan C R Jones; Chen Yuan Kam; Robert M Harmon; Alexandra V Woychek; Susan B Hopkinson; Kathleen J Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-01-03       Impact factor: 10.005

3.  FRMBP2 directs NOD2 to the membrane.

Authors:  Amrita Kabi; Christine McDonald
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

Review 4.  NOD1 and NOD2: Beyond Peptidoglycan Sensing.

Authors:  A Marijke Keestra-Gounder; Renée M Tsolis
Journal:  Trends Immunol       Date:  2017-08-16       Impact factor: 16.687

5.  The role of intermediate filaments in maintaining integrity and function of intestinal epithelial cells after massive bowel resection in a rat.

Authors:  I Sukhotnik; Y Ben Shahar; Y Pollak; T Dorfman; H Kreizman Shefer; Z E Assi; N Mor-Vaknin; A G Coran
Journal:  Pediatr Surg Int       Date:  2017-10-17       Impact factor: 1.827

Review 6.  Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicity.

Authors:  Margarita Martinez-Medina; Librado Jesus Garcia-Gil
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

7.  Methods for Determining the Cellular Functions of Vimentin Intermediate Filaments.

Authors:  Karen M Ridge; Dale Shumaker; Amélie Robert; Caroline Hookway; Vladimir I Gelfand; Paul A Janmey; Jason Lowery; Ming Guo; David A Weitz; Edward Kuczmarski; Robert D Goldman
Journal:  Methods Enzymol       Date:  2015-12-19       Impact factor: 1.600

8.  Systematic review: gastrointestinal infection and incident inflammatory bowel disease.

Authors:  Jordan E Axelrad; Ken H Cadwell; Jean-Frederic Colombel; Shailja C Shah
Journal:  Aliment Pharmacol Ther       Date:  2020-05-05       Impact factor: 8.171

9.  The vimentin intermediate filament network restrains regulatory T cell suppression of graft-versus-host disease.

Authors:  Cameron McDonald-Hyman; James T Muller; Michael Loschi; Govindarajan Thangavelu; Asim Saha; Sudha Kumari; Dawn K Reichenbach; Michelle J Smith; Guoan Zhang; Brent H Koehn; Jiqiang Lin; Jason S Mitchell; Brian T Fife; Angela Panoskaltsis-Mortari; Colby J Feser; Andrew Kemal Kirchmeier; Mark J Osborn; Keli L Hippen; Ameeta Kelekar; Jonathan S Serody; Laurence A Turka; David H Munn; Hongbo Chi; Thomas A Neubert; Michael L Dustin; Bruce R Blazar
Journal:  J Clin Invest       Date:  2018-08-14       Impact factor: 14.808

Review 10.  The cytoskeleton in cell-autonomous immunity: structural determinants of host defence.

Authors:  Serge Mostowy; Avinash R Shenoy
Journal:  Nat Rev Immunol       Date:  2015-08-21       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.